eNauka - pregled

Pregled prema Autor Kim, Tae Won

Prikaz rezultata 1 do 4 od 4
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2016A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancerKim, Tae Won; ...; Manojlovic, Nebojsa S  ; ...; (broj, koautora 16)Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2016An open label, randomized phase III trial evaluating the treatment (tx) effects of panitumumab (pmab) plus best supportive care (BSC) versus BSC in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) and in WT RAS mCRC.Kim, Tae Won; ...; (broj, koautora 16)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal CancerKim, Tae Won; Elme, Anneli; Park, Joon Oh; Udrea, Anghel Adrian; Kim, Sun Young; Ahn, Joong Bae; Valencia, Ricardo Villalobos; Krishnan, Srinivasan; Manojlović, Nebojša S.  ; Guan, Xuesong;
Lofton-Day, Catherine; Jung, A Scott; Vrdoljak, Eduard;
Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2016Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).Kim, Tae Won; ...; Kusic, Zvonko; ...; Manojlović, Nebojša S.  ; ...; (broj, koautora 16)Konferencijski rad
Mp kategorija će biti prikazana naknadno.
Prikaz rezultata 1 do 4 od 4